Indutrade acquires the Italian medtech company SLT

Indutrade has signed an agreement to acquire all shares in the Italian company SLT srl, www.sltsrl.com, with annual sales of approximately EUR 7.5 million (SEK 85 million).

SLT is a technical trading company offering testing and safety control devices for the medical technology and healthcare sectors. The company specialises in products for safety and performance verification of medical equipment and bioimaging, complemented with calibration services and training programs. Customers include OEM’s which produce medical equipment, global service providers and hospitals. SLT was founded in 1949, has 19 employees and is located in Milan, Italy.

“SLT has a leading market position in a well-defined niche and a unique offering built on high technical know-how. We welcome SLT and its team to Indutrade”, said Bo Annvik, President and CEO of Indutrade.

The closing is expected to be finalised during Q3 2025. SLT will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's fifth in 2025 and is expected to have a marginally positive impact on Indutrade's earnings per share.

Datum 2025-07-31, kl 08:30
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!